O[C@H]1[C@H](O)[C@@H](Cn2nnc(-c3ccccc3)c2-c2ccccc2)OCO[C@@H]1Cn1nnc(-c2ccccc2)c1-c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?